Literature DB >> 20375207

Peptide YY levels across pubertal stages and associations with growth hormone.

Benjamin Lloyd1, Praful Ravi, Nara Mendes, Anne Klibanski, Madhusmita Misra.   

Abstract

CONTEXT: Changes in appetite-regulating peptides may impact food intake during puberty and facilitate the pubertal growth spurt. Peptide YY (PYY) is an anorexigenic hormone that is high in anorexia nervosa and low in obesity, inhibits GnRH secretion, and is suppressed by GH administration. The relationship between PYY and GH has not been examined across puberty.
OBJECTIVES: We hypothesized that PYY would be inversely associated with GH in adolescents and would be lowest when GH is highest. DESIGN AND
SETTING: We conducted a cross-sectional study at a Clinical Research Center.
SUBJECTS: We studied 87 children, 46 boys and 41 girls ages 9-17 yr at Tanner stages 1-5 of puberty (10th-90th percentiles for body mass index). OUTCOME MEASURES: We measured fasting PYY and nadir GH levels after administration of an oral glucose load. Leptin levels were also measured.
RESULTS: Fasting PYY was lowest and nadir GH highest in boys in Tanner stages 3-4 (P = 0.02) and in girls in Tanner stages 2-3 (P = 0.02). Leptin levels were highest in early pubertal boys and late pubertal girls. For the group as a whole and within genders, even after controlling for body mass index, log nadir GH correlated inversely with log PYY (P = 0.003, 0.07, and 0.02). PYY levels did not correlate with leptin levels.
CONCLUSIONS: During mid-puberty, at a time when GH levels are the highest, PYY is at a nadir, and these low PYY levels may facilitate pubertal progression and growth.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20375207      PMCID: PMC2902078          DOI: 10.1210/jc.2009-2496

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  22 in total

1.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Normal reference laboratory values.

Authors: 
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

2.  Cluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection.

Authors:  J D Veldhuis; M L Johnson
Journal:  Am J Physiol       Date:  1986-04

3.  Bmi in childhood and its association with height gain, timing of puberty, and final height.

Authors:  Q He; J Karlberg
Journal:  Pediatr Res       Date:  2001-02       Impact factor: 3.756

4.  Growth hormone suppression after an oral glucose load in children.

Authors:  Madhusmita Misra; Jennalee Cord; Rajani Prabhakaran; Karen K Miller; Anne Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2007-09-18       Impact factor: 5.958

5.  Growth hormone and ghrelin responses to an oral glucose load in adolescent girls with anorexia nervosa and controls.

Authors:  Madhusmita Misra; Karen K Miller; David B Herzog; Kavitha Ramaswamy; Avichal Aggarwal; Cecilia Almazan; Gregory Neubauer; Jeffrey Breu; Anne Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2004-04       Impact factor: 5.958

6.  Analysis of 24-hour growth hormone profiles in healthy boys and girls of normal stature: relation to puberty.

Authors:  K Albertsson-Wikland; S Rosberg; J Karlberg; T Groth
Journal:  J Clin Endocrinol Metab       Date:  1994-05       Impact factor: 5.958

7.  Spontaneous growth hormone secretion increases during puberty in normal girls and boys.

Authors:  S R Rose; G Municchi; K M Barnes; G A Kamp; M M Uriarte; J L Ross; F Cassorla; G B Cutler
Journal:  J Clin Endocrinol Metab       Date:  1991-08       Impact factor: 5.958

8.  Pulsatile growth hormone release in normal women during the menstrual cycle.

Authors:  A C Faria; L W Bekenstein; R A Booth; V A Vaccaro; C M Asplin; J D Veldhuis; M O Thorner; W S Evans
Journal:  Clin Endocrinol (Oxf)       Date:  1992-06       Impact factor: 3.478

9.  Endogenous growth hormone secretion and clearance rates in normal boys, as determined by deconvolution analysis: relationship to age, pubertal status, and body mass.

Authors:  P M Martha; K M Gorman; R M Blizzard; A D Rogol; J D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  1992-02       Impact factor: 5.958

10.  Inhibition of food intake in obese subjects by peptide YY3-36.

Authors:  Rachel L Batterham; Mark A Cohen; Sandra M Ellis; Carel W Le Roux; Dominic J Withers; Gary S Frost; Mohammad A Ghatei; Stephen R Bloom
Journal:  N Engl J Med       Date:  2003-09-04       Impact factor: 91.245

View more
  5 in total

Review 1.  Bone health and the female athlete triad in adolescent athletes.

Authors:  Kathryn E Ackerman; Madhusmita Misra
Journal:  Phys Sportsmed       Date:  2011-02       Impact factor: 2.241

2.  Changes in appetite-regulating hormones following food intake are associated with changes in reported appetite and a measure of hedonic eating in girls and young women with anorexia nervosa.

Authors:  Christopher Mancuso; Alyssa Izquierdo; Meghan Slattery; Kendra R Becker; Franziska Plessow; Jennifer J Thomas; Kamryn T Eddy; Elizabeth A Lawson; Madhusmita Misra
Journal:  Psychoneuroendocrinology       Date:  2019-12-23       Impact factor: 4.905

Review 3.  Systematic review and meta-analysis of the effect of meal intake on postprandial appetite-related gastrointestinal hormones in obese children.

Authors:  K Nguo; K Z Walker; M P Bonham; C E Huggins
Journal:  Int J Obes (Lond)       Date:  2015-12-21       Impact factor: 5.095

4.  Changes in Sex Steroids and Enteric Peptides After Sleeve Gastrectomy in Youth in Relation to Changes in Bone Parameters.

Authors:  Supritha Nimmala; Snimarjot Kaur; Vibha Singhal; Deborah M Mitchell; Fatima Cody Stanford; Mary L Bouxsein; Meghan Lauze; Carolyn Huynh; Clarissa C Pedreira; Hang Lee; Miriam A Bredella; Madhusmita Misra
Journal:  J Clin Endocrinol Metab       Date:  2022-08-18       Impact factor: 6.134

5.  Gut hormone activity of children born to women with and without gestational diabetes.

Authors:  P C Chandler-Laney; N C Bush; D J Rouse; M S Mancuso; B A Gower
Journal:  Pediatr Obes       Date:  2013-01-31       Impact factor: 4.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.